3D in vitro tissue models and their potential for drug screening
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: The development of one standard, simplified in vitro three-dimensional tissue model suitable to biological and pathological investigation and drug-discovery may not yet be feasible, but standardized models for individual tissues or organs are a possibility. Tissue bioengineering, while concerned with finding methods of restoring functionality in disease, is developing technology that can be miniaturized for high throughput screening (HTS) of putative drugs. Through collaboration between biologists, physicists and engineers, cell-based assays are expanding into the realm of tissue analysis. Accordingly, three-dimensional (3D) micro-organoid systems will play an increasing role in drug testing and therapeutics over the next decade. Nevertheless, important hurdles remain before these models are fully developed for HTS. AREAS COVERED: We highlight advances in the field of tissue bioengineering aimed at enhancing the success of drug candidates through pre-clinical optimization. We discuss models that are most amenable to high throughput screening with emphasis on detection platforms and data modeling. EXPERT OPINION: Modeling 3D tissues to mimic in-vivo architecture remains a major challenge. As technology advances to provide novel methods of HTS analysis, so do potential pitfalls associated with such models and methods. We remain hopeful that integration of biofabrication with HTS will significantly reduce attrition rates in drug development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction
Berridge, M. V., Herst, P. M., & Tan, A. S. (2005) · Biotechnology Annual Review · doi:10.1016/s1387-2656(05)11004-7 · Cited by 2,222 · cited 1×
“Common methods to determine viability involve measurement of mitochondrial activity with the MTT assay or its variations [67].”
MethodVascularized and functional human liver from an iPSC-derived organ bud transplant
Takebe, T., Sekine, K., Enomura, M., Koike, H., Kimura, M., Ogaeri, T., Zhang, R.-R., Ueno, Y., Zheng, Y.-W., Koike, N., et al. (2013) · Nature · doi:10.1038/nature12271 · Cited by 2,170 · cited 1×
“reported cocultured iPSCs support liver formation in vitro, which have the potential to replace dysfunctional areas of the liver [47].”
BackgroundDeconstructing the third dimension – how 3D culture microenvironments alter cellular cues
Baker, B. M., & Chen, C. S. (2012) · Journal of Cell Science · doi:10.1242/jcs.079509 · Cited by 1,760
Multicellular tumor spheroids: An underestimated tool is catching up again
Hirschhaeuser, F., Menne, H., Dittfeld, C., West, J., Mueller-Klieser, W., & Kunz-Schughart, L. A. (2010) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2010.01.012 · Cited by 1,674
Microscale culture of human liver cells for drug development
Khetani, S. R., & Bhatia, S. N. (2008) · Nature Biotechnology · doi:10.1038/nbt1361 · Cited by 1,219 · cited 1×
“Biomarkers related to cell-cell interaction, such as ICAMs, can also serve as surrogate endpoints to predict toxicity in 3D cultures [73].”
BackgroundOpportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy
Mehta, G., Hsiao, A. Y., Ingram, M., Luker, G. D., & Takayama, S. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.04.045 · Cited by 1,172 · cited 1×
“We agree with Mehta [79] that key challenges are associated with creation of uniformly-sized spheroids, spheroids with small number of cells, and co-cultures.”
BackgroundSpheroid culture as a tool for creating 3D complex tissues
Fennema, E., Rivron, N., Rouwkema, J., van Blitterswijk, C., & de Boer, J. (2013) · Trends in Biotechnology · doi:10.1016/j.tibtech.2012.12.003 · Cited by 1,054 · cited 3×
“Recent advances in the semiconductor industry allow manufacturing greater numbers of spheroid culture wells of smaller sizes while using alternative materials such as agarose [13].”
BackgroundMethodArtificial niche microarrays for probing single stem cell fate in high throughput
Gobaa, S., Hoehnel, S., Roccio, M., Negro, A., Kobel, S., & Lutolf, M. P. (2011) · Nature Methods · doi:10.1038/nmeth.1732 · Cited by 390 · cited 2×
“Modeling the microenvironment has gained importance with the recognition that the stem cell niche governs its activation, differentiation and is extremely important in tissue repair [7,10].”
BackgroundMethodFey, S. J., & Wrzesinski, K. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfs122 · Cited by 188
Shin, M. K., Kim, S. K., & Jung, H. (2011) · Lab on a Chip · doi:10.1039/c1lc20671k · Cited by 94 · cited 2×
“Overall metastasis potential was determined by the ability of metastatic cells to adhere to endothelial cells (EGFR-FITC antibody selectively binds to the cancer cells in the cluster) followed by the recovery of single cancer cells out of the extravasation chamber under constant fluid flow [20].”
Background
Cited by
Engineering cancer microenvironments for in vitro 3-D tumor models
Asghar, W., El Assal, R., Shafiee, H., Pitteri, S., Paulmurugan, R., & Demirci, U. (2015) · Materials Today · doi:10.1016/j.mattod.2015.05.002 · Cited by 316
3D Bioprinting of Tissue/Organ Models
Pati, F., Gantelius, J., & Svahn, H. A. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201505062 · Cited by 301
Dereplication: racing to speed up the natural products discovery process
Gaudêncio, S. P., & Pereira, F. (2015) · Natural Product Reports · doi:10.1039/c4np00134f · Cited by 264
Fibrotic microtissue array to predict anti-fibrosis drug efficacy
Asmani, M., Velumani, S., Li, Y., Wawrzyniak, N., Hsia, I., Chen, Z., Hinz, B., & Zhao, R. (2018) · Nature Communications · doi:10.1038/s41467-018-04336-z · Cited by 137
Current advances in three-dimensional tissue/organ printing
Park, J. H., Jang, J., Lee, J.-S., & Cho, D.-W. (2016) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-016-8111-8 · Cited by 51
Metadata
- Authors
- Kimlin, L., Kassis, J., & Virador, V.
- Venue
- Expert Opinion on Drug Discovery
- Publisher
- Informa Healthcare
- Published
- 2013-10-22
- Volume
- 8
- Issue
- 12
- Pages
- 1455-1466
- ISSN
- 1746-0441 (ISSN-L)
- 1746-045X
- OpenAlex
- W2120772428
- Cited by
- 79
- References
- 11
- FWCI
- 4.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: 3D in vitro tissue models and their potential for drug screening. https://app.cochat.ai/papers/10.1517/17460441.2013.852181
- The paper
- Kimlin, L., Kassis, J., & Virador, V. (2013). 3D in vitro tissue models and their potential for drug screening. Expert Opinion on Drug Discovery. https://doi.org/10.1517/17460441.2013.852181
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.